The company said, “The company expects sales growth from continuing operations of 4% to 5% on a reported basis and 1% to 2% on an operational basis. The company expects adjusted earnings from continuing operations, before special items, of $0.59 to $0.63 per diluted share.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAX:
- Baxter call volume above normal and directionally bullish
- Is BAX a Buy, Before Earnings?
- Baxter participates in a conference call with JPMorgan
- Baxter International: Navigating Leadership Transition and Market Growth Amidst Tariff Challenges
- Baxter International Appoints New Leadership Amid Strategic Changes